Morrison, Mary S.
Wang, Tina
Raguram, Aditya
Hemez, Colin http://orcid.org/0000-0003-3445-7706
Liu, David R. http://orcid.org/0000-0003-0346-5033
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01 AI142756)
Howard Hughes Medical Institute (Liu Investigatorship)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB031172)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Article History
Received: 7 August 2021
Accepted: 27 September 2021
First Online: 13 October 2021
Change Date: 17 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-021-27102-0
Competing interests
: M.S.M., T.W., A.R., C.H., and D.R.L. have filed a provisional patent application through the Broad Institute on the periplasmic PACE system and related improvements. D.R.L. is a co-founder and consultant of Chroma Medicine and Resonance Medicine, companies that may use PACE technologies.